TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - QIAGEN Stock

Certificat

DE000SW19WM0

Delayed Deutsche Boerse AG 07:12:36 2024-07-03 EDT
0.89 EUR +1.14% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - QIAGEN
1 month-18.52%
3 months-20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-03 0.89 +1.14%
24-07-02 0.88 +6.02%
24-07-01 0.83 -5.68%
24-06-28 0.88 -5.38%
24-06-27 0.93 +4.49%

Delayed Quote Deutsche Boerse AG

Last update July 03, 2024 at 07:12 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying QIAGEN N.V.
IssuerLogo Issuer Société Générale Société Générale
WKN SW19WM
ISINDE000SW19WM0
Date issued 2023-08-15
Strike 29.1
Maturity Unlimited
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.55
Lowest since issue 0.59
Spread 0.01
Spread %1.11%

Company Profile

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Sector
-
More about the company

Ratings for Qiagen N.V.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Qiagen N.V.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
40.7 USD
Average target price
50.37 USD
Spread / Average Target
+23.75%
Consensus